Autres langues GlucoTrack, Inc.

Actions

GCTK

US45824Q5071

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 10/05/2024			Varia. 5j.	Varia. 1 janv.
0,5602 ^USD	-0,50%		-8,16%	+114,23%

16/04	GlucoTrack, Inc. annonce l'extension de sa technologie de surveillance continue du glucose à la surveillance épidurale du glucose	CI
02/04	Glucotrack annonce une longévité accrue du capteur pour son moniteur de glucose sanguin continu implantable	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION	02/05
GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT	22/04
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK	22/04
GlucoTrack, Inc. announced that it has received $0.5 million in funding	22/04
Glucotrack Expanding Glucose Monitoring Technology to Epidural Space	16/04
GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING	16/04
GlucoTrack, Inc. Announces Expansion of its Continues Glucose Monitoring Technology to Epidural Glucose Monitoring	16/04
GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR	02/04
Glucotrack Announces Increased Sensor Longevity for Its Implantable Continuous Blood Glucose Monitor	02/04
GlucoTrack, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY	12/03
GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR	27/02
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS	13/02
Glucotrack, Inc Announces Appointment of Luis Malavé as Chairman of Its Board of Directors	13/02
GlucoTrack Inc. : GlucoTrack veröffentlicht die ersten Daten zur Messgenauigkeit seines implantierbaren Geräts für die kontinuierliche Glukoseüberwachung	08/02
GlucoTrack Says Implantable Glucose Monitor Safe With High Level of Accuracy; Shares Rise	02/01
GlucoTrack, Inc. Announces Early Accuracy Data for its Implantable Continuous Glucose Monitor	02/01
GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR	02/01
GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT	30/11
GlucoTrack, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues GlucoTrack, Inc.

Actions

GCTK

US45824Q5071

Autres langues

Filtres